TrialBritish journal of cancer2005

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration.

A Wardley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.